Rostral Ventrolateral Medulla Sympathetic Neurons
Introduction <table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">Rostral Ventrolateral Medulla Sympathetic Neurons</th> </tr> <tr> <td class="label">Category </td> <td>Brainstem Autonomic Nervous System</td> </tr> <tr> <td class="label">Location </td> <td>Rostral ventrolateral medulla, rostral to the obex</td> </tr> <tr> <td class="label">Cell Types </td> <td>Sympathetic premotor (C1 adrenergic)</td> </tr> <tr> <td class="label">Primary Neurotransmitter </td> <td>Glutamate, Adrenaline</td> </tr> <tr> <td class="label">Key Markers </td> <td>VGLUT2, TH, C1 adrenergic neurons, Phox2b</td> </tr> <tr> <td class="label">Projection Target </td> <td>Intermediolateral cell column (IML), spinal cord</td> </tr> <tr> <td class="label">Afferent Inputs </td> <td>NTS, paraventricular nucleus, hypothalamus</td> </tr> <tr> <td class="label">Transmitter</td> <td>Role</td> </tr> <tr> <td class="label">Glutamate</td> <td>Main excitatory transmitter to IML</td> </tr> <tr> <td class="label">Adrenaline (C1)</td> <td>Modulatory, enhances sympathetic tone</td> </tr> <tr> <td class="label">Substance P</td> <td>Co-transmitter in some neurons</td> </tr> <tr> <td class="label">Neuropeptide Y</td> <td>Inhibits baroreceptor reflex</td> </tr> <tr> <td class="label">Drug Class</td> <td>RVLM Mechanism</td> </tr> <tr> <td class="label">B
...
Rostral Ventrolateral Medulla Sympathetic Neurons
Introduction <table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">Rostral Ventrolateral Medulla Sympathetic Neurons</th> </tr> <tr> <td class="label">Category </td> <td>Brainstem Autonomic Nervous System</td> </tr> <tr> <td class="label">Location </td> <td>Rostral ventrolateral medulla, rostral to the obex</td> </tr> <tr> <td class="label">Cell Types </td> <td>Sympathetic premotor (C1 adrenergic)</td> </tr> <tr> <td class="label">Primary Neurotransmitter </td> <td>Glutamate, Adrenaline</td> </tr> <tr> <td class="label">Key Markers </td> <td>VGLUT2, TH, C1 adrenergic neurons, Phox2b</td> </tr> <tr> <td class="label">Projection Target </td> <td>Intermediolateral cell column (IML), spinal cord</td> </tr> <tr> <td class="label">Afferent Inputs </td> <td>NTS, paraventricular nucleus, hypothalamus</td> </tr> <tr> <td class="label">Transmitter</td> <td>Role</td> </tr> <tr> <td class="label">Glutamate</td> <td>Main excitatory transmitter to IML</td> </tr> <tr> <td class="label">Adrenaline (C1)</td> <td>Modulatory, enhances sympathetic tone</td> </tr> <tr> <td class="label">Substance P</td> <td>Co-transmitter in some neurons</td> </tr> <tr> <td class="label">Neuropeptide Y</td> <td>Inhibits baroreceptor reflex</td> </tr> <tr> <td class="label">Drug Class</td> <td>RVLM Mechanism</td> </tr> <tr> <td class="label">Beta-blockers</td> <td>Reduce central sympathetic output</td> </tr> <tr> <td class="label">Alpha-2 agonists</td> <td>Inhibit RVLM firing</td> </tr> <tr> <td class="label">Centrally acting agents</td> <td>Clonidine, methyldopa</td> </tr> <tr> <td class="label">ACE inhibitors</td> <td>Reduce angiotensin II in RVLM</td> </tr> </table>
The rostral ventrolateral medulla (RVLM) is the primary sympathetic vasomotor center in the brainstem and contains C1 adrenergic [neurons](/entities/neurons) that are essential for maintaining baseline blood pressure and sympathetic tone. These neurons project directly to sympathetic preganglionic neurons in the intermediolateral cell column of the spinal cord, making them the final common pathway for supraspinal sympathetic control. [@dampney1994]
The RVLM receives input from the nucleus tractus solitarius (NTS), the hypothalamic pressor area, and higher cortical regions, integrating cardiovascular, respiratory, and emotional information to generate appropriate sympathetic responses. Dysfunction in RVLM neurons contributes to hypertension, autonomic failure in multiple system atrophy (MSA), and sleep-related breathing disorders. [@guyenet2006]
Overview
Mermaid diagram (expand to render)
Normal Function
Vasomotor Control The RVLM is the primary determinant of sympathetic vasomotor tone:
Baseline Tone : RVLM neurons maintain ~2-3 Hz firing at rest, setting vascular resistance
Baroreceptor Reflex : Receives inhibitory input from the NTS during blood pressure rises
Chemical Control : Sensitive to changes in PaO2, PaCO2, and pH
Cardiovascular Regulation RVLM neurons control:
Arterial Pressure : Via vasoconstriction of resistance vessels
Heart Rate : Indirectly through cardiac sympathetic nerve activity
Venous Return : Through splanchnic vein constriction
Integration with Other Systems The RVLM integrates multiple inputs:
Cardiovascular : Baroreceptor, chemoreceptor, cardiopulmonary afferents
Respiratory : Coordinate sympathetic activity with breathing
Emotional : Stress responses via amygdala and hypothalamus
Neuroanatomy
Location and Structure The RVLM is located in the ventrolateral medulla oblongata, approximately 2-4 mm rostral to the obex. The region contains:
C1 Neurons : Adrenergic neurons (~15% of RVLM neurons)
Non-C1 Glutamatergic Neurons : Majority of presympathetic neurons
Glycinergic Inhibitory Interneurons : Modulate output
Projection Patterns RVLM neurons project to:
Intermediolateral Cell Column (IML) : Sympathetic preganglionic neurons (T1-L2)
Nucleus of the Solitary Tract : Feedback modulation
Paraventricular Nucleus of Hypothalamus : Integration
Neurochemistry
Disease Vulnerability
Hypertension RVLM hyperactivity contributes to essential hypertension:
Increased sympathetic tone in ~50% of hypertensive patients
Reduced baroreceptor sensitivity
Possible role in resistant hypertension
Multiple System Atrophy MSA involves:
Loss of RVLM neurons
Severe autonomic failure
Orthostatic hypotension
Supine hypertension
Obstructive Sleep Apnea RVLM dysfunction in OSA:
Chronic intermittent hypoxia sensitizes RVLM
Increased sympathetic activity during sleep
Contributes to daytime hypertension
Parkinson's Disease PD can involve autonomic dysfunction:
RVLM involvement in some patients
Contributes to orthostatic hypotension
May relate to non-motor symptoms
Molecular Mechanisms
C1 Adrenergic Neurons The C1 neurons in the RVLM are unique:
Express tyrosine hydroxylase (TH)
Release adrenaline as a co-transmitter
Express glucocorticoid receptors
Sensitive to hypoxia
Sympathetic Overactivity Mechanisms In hypertension:
Reduced GABAergic Inhibition : From NTS and baroreceptor input
Increased Glutamatergic Excitation : From hypothalamus and [cortex](/brain-regions/cortex)
Angiotensin II Sensitization : Within the RVLM
Oxidative Stress : In RVLM neurons
Therapeutic Implications
Antihypertensive Drugs
Deep Brain Stimulation Experimental approaches:
RVLM DBS for refractory hypertension
May reduce sympathetic tone
Still experimental
Sleep Apnea Treatment
CPAP reduces RVLM sympathetic overactivity
Lowering sympathetic tone improves outcomes
See Also
[Nucleus Tractus Solitarius](/cell-types/nucleus-tractus-solitarius)
[Intermediolateral Cell Column](/cell-types/intermediolateral-cell-column-neurons)
[Locus Coeruleus](/cell-types/locus-coeruleus-noradrenergic-projection-neurons)
[Multiple System Atrophy](/diseases/multiple-system-atrophy)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Hypertension](/diseases/hypertension)
[Blood-Brain Barrier](/mechanisms/blood-brain-barrier)
External Links
[PubMed - Autonomic Neuroscience](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[American Heart Association](https://www.heart.org/) - Cardiovascular research
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
Background The study of Rostral Ventrolateral Medulla Sympathetic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Show full description